SMTL ID : 6q4i.1

CDK2 in complex with FragLite35

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.11 Å

Oligo State

monomer

Ligands

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 5 residues within 4Å: Chain A: M.9, E.10, N.11, F.12, I.78 1 PLIP interactions: 1 interactions with chain A Water bridges: A:E.10

1 x HGK: 2-[4-[(2-oxidanylidene-3~{H}-pyridin-4-yl)oxy]phenyl]ethanoic acid(Non-covalent)

HGK.2: 14 residues within 4Å: Chain A: I.18, E.20, G.21, T.22, V.26, A.39, K.41, E.89, F.90, L.91, K.137, Q.139, L.142, D.153 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.18, A:V.26, A:A.39, A:Q.139, A:L.142 Hydrogen bonds: A:T.22, A:T.22, A:K.41, A:L.91, A:Q.139, A:D.153 Water bridges: A:N.140 Salt bridges: A:K.137

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wood, D.J. et al., FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation. J.Med.Chem. (2019)

Release Date

2019-03-20

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2